Visara appoints ophthalmology leaders to advance VIS-101 drug program

Go back to Visara appoints ophthalmology leaders to advance VIS-101 drug program
(NASDAQ: AURA) Delayed: 6.18 -0.12 (1.9%)
Previous Close $6.30    52 Week High $ 
Open $6.31    52 Week Low $ 
Day High $6.42    P/E N/A 
Day Low $6.15    EPS $ 
Volume 907,586       

(NASDAQ: FDMT) Delayed: 11.03 +0.23 (2.13%)
Previous Close $10.80    52 Week High $ 
Open $10.74    52 Week Low $ 
Day High $11.29    P/E N/A 
Day Low $10.62    EPS $ 
Volume 1,084,578       

(NASDAQ: NBP) Delayed: 1.22 -0.15 (10.95%)
Previous Close $1.37    52 Week High $6.95 
Open $1.39    52 Week Low $6.95 
Day High $1.39    P/E 0.57 
Day Low $1.21    EPS $2.14 
Volume 818,329